CODX logo

Co-Diagnostics (CODX)

Profile

Full Name

Co-Diagnostics, Inc.

Ticker Symbol

CODX

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

July 12, 2017

Indexes

Not included

Website

http://co-dx.com

Employees

132

Key Details

Price

$0.35(-3.58%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.92M(-42.52% YoY)

Annual EPS

-$1.24(-3.33% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.35
CODX price is $0.35

30-Day Relative Volume

0.04
CODX 30-day relative volume is 0.04

Price Performance

Price Most recent change

-3.58%
CODX price was down -3.58% on Apr 15, 2025

Price YTD change

-53.33%
CODX price is down -53.33% since January 1st

Price 1-year change

-70.09%
CODX price is down -70.09% year-on-year

Price 3-year change

-93.78%
CODX price is down -93.78% over the past 3 years

Price Range

Price All-time high

$30.99
CODX price is currently -98.87% below its historical high of $30.99

Price 3-year low

$0.28
CODX price is currently +25.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.18M
CODX market capitalization is $11.18 million

Market cap 3-year change

-94.16%
CODX market capitalization is down -94.16% over the past 3 years

Market cap All-time high

$862.12M
CODX market capitalization is currently -98.70% below its historical high of $862.12 million

Market cap sector rank

21.38%
CODX market capitalization is higher than 21.38% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.08%
CODX shares outstanding is up +2.08% year-on-year

Shares Outstanding 3-Year Change

-6.04%
CODX shares outstanding is down -6.04% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.31
CODX beta is 1.31

200-day SMA

$0.96
CODX price is currently -63.62% below its 200-day simple moving average

50-day SMA

$0.50
CODX price is currently -30.50% below its 50-day simple moving average

RSI

40.09
CODX 14-day relative strength index is 40.09

Volume

0.04
CODX 30-day relative volume is 0.04

ATR

$0.06
CODX average true range is $0.06

10-day Historical Volatility

115.98%
CODX 10-day historical volatility is 115.98%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.92M
CODX annual revenue is $3.92 million

Revenue Analysts estimate

$1.50M
CODX annual revenue is currently +161.01% higher than the consensus analysts' forecast

Revenue 1-year change

-42.52%
CODX annual revenue is down -42.52% year-on-year

Revenue Sector rank

20.45%
CODX annual revenue is higher than 20.45% of companies in Healthcare sector

EPS

EPS

-$1.24
CODX annual earnings per share is -$1.24

EPS Analysts estimate

-$0.91
CODX annual earnings per share is currently +36.26% higher than the consensus analysts' forecast

EPS 1-year change

-3.33%
CODX annual earnings per share is down -3.33% year-on-year

EPS Sector rank

51.12%
CODX annual earnings per share is higher than 51.12% of companies in Healthcare sector

Profit

Gross profit

$2.92M
CODX annual gross profit is $2.92 million

Gross margin

74.48%
CODX annual gross profit margin is 74.48%

Operating profit

-$40.08M
CODX annual operating income is -$40.08 million

Operating margin

-1023.75%
CODX annual operating profit margin is -1023.75%

Net income

-$37.64M
CODX annual net profit is -$37.64 million

Net margin

-961.37%
CODX annual net profit margin is -961.37%

Expenses

Total expenses

$44.00M
CODX annual total expenses is $44.00 million

Operating expenses

$43.00M
CODX annual total operating expenses is $43.00 million

Cost of goods sold

$999.10K
CODX annual cost of goods sold is $999.10 thousand

Selling, general & administrative expenses

$20.64M
CODX annual SGA is $20.64 million

Depreciation and amortization

$1.38M
CODX annual depreciation & amortization is $1.38 million

Interest expense

-
CODX annual interest expense value is unknown

Income tax

$57.40K
CODX annual income tax is $57.40 thousand

EBIT & EBITDA

EBIT

-$40.08M
CODX annual earnings before interest & taxes is -$40.08 million

EBITDA

-$38.70M
CODX annual EBITDA is -$38.70 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$64.00M
CODX annual total assets is $64.00 million

Non current assets

$31.71M
CODX annual long term assets is $31.71 million

Current assets

$32.29M
CODX annual total current assets is $32.29 million

Cash and cash equivalents

$2.94M
CODX annual cash & cash equivalents is $2.94 million

Accounts receivable

$132.60K
CODX annual accounts receivable is $132.60 thousand

Inventory

$1.07M
CODX annual inventory is $1.07 million

Liabilities

Total liabilities

$9.69M
CODX annual total liabilities is $9.69 million

Long term liabilities

$2.37M
CODX annual total long term liabilities is $2.37 million

Current liabilities

$7.32M
CODX annual total current liabilities is $7.32 million

Accounts payable

$3.29M
CODX annual accounts payable is $3.29 million

Debt

Total debt

$2.15M
CODX annual total debt is $2.15 million

Total debt 1-year change

-28.03%
CODX annual total debt is down -28.03% year-on-year

Long term debt

$1.24M
CODX annual long term debt is $1.24 million

Short term debt

$915.60K
CODX annual short term debt is $915.60 thousand

Equity & Capital

Shareholders equity

$54.31M
CODX annual stockholders equity is $54.31 million

Book value

$54.31M
CODX annual book value is $54.31 million

Retained earnings

-$33.04M
CODX annual retained earnings is -$33.04 million

Working capital

$24.98M
CODX annual working capital is $24.98 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$29.16M
CODX annual cash flow from operations is -$29.16 million

Cash from operations 1-year change

-32.03%
CODX annual cash flow from operations is down -32.03% year-on-year

Cash from investing

$17.07M
CODX annual cash flow from investing activities is $17.07 million

Cash from investing 1-year change

+10.93%
CODX annual cash flow from investing activities is up +10.93% year-on-year

Cash from financing

$103.90K
CODX annual cash flow from financing activities is $103.90 thousand

Cash from financing 1-year change

+107.62%
CODX annual cash flow from financing activities is up +107.62% year-on-year

CAPEX

CAPEX

$748.40K
CODX annual capital expenditures is $748.40 thousand

CAPEX 1-year change

-45.18%
CODX annual capital expenditures is down -45.18% year-on-year

Free Cash Flow

Free cash flow

-$29.90M
CODX annual free cash flow is -$29.90 million

Free cash flow 1-year change

-27.54%
CODX annual free cash flow is down -27.54% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

74.48%
CODX annual gross profit margin is 74.48%

Operating margin

-1023.75%
CODX annual operating profit margin is -1023.75%

Net margin

-961.37%
CODX annual net profit margin is -961.37%

ROA & ROE

ROA

-47.25%
CODX annual return on assets is -47.25%

ROE

-53.65%
CODX annual return on equity is -53.65%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CODX price to earnings ratio value is unknown

PE ratio Sector rank

-
CODX price to earnings ratio is unknown

PB Ratio

PB ratio

0.21
CODX price to book ratio is 0.21

PB ratio Sector rank

20%
CODX price to book ratio is higher than 20% of companies in Healthcare sector

PS Ratio

PS ratio

3.02
CODX price to sales ratio is 3.02

PS ratio Sector rank

52.18%
CODX price to sales ratio is higher than 52.18% of companies in Healthcare sector

Enterprise value

Enterprise value

$10.39M
CODX enterprise value is $10.39 million

Enterprise value Sector rank

25.14%
CODX enterprise value is higher than 25.14% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.27
CODX EV/EBITDA is -0.27

EV/EBITDA Sector rank

56.92%
CODX EV/EBITDA is higher than 56.92% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.41
CODX annual current ratio is 4.41

Quick ratio

4.27
CODX annual quick ratio is 4.27

Leverage

Debt to equity

0.00
CODX annual debt to equity ratio is 0.00

Interest coverage ratio

-
CODX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

2
CODX piotroski f-score is 2

Altman Z-Score

-1.57
CODX altman z-score is -1.57

Analyst ratings

Recent major analysts updates

Mar 28, 25 HC Wainwright & Co.
Neutral
Nov 11, 24 HC Wainwright & Co.
Neutral
Aug 12, 24 HC Wainwright & Co.
Neutral
Jun 17, 24 HC Wainwright & Co.
Neutral
May 13, 24 HC Wainwright & Co.
Neutral
Mar 15, 24 HC Wainwright & Co.
Neutral
Dec 29, 23 HC Wainwright & Co.
Neutral
Nov 13, 23 HC Wainwright & Co.
Neutral
Aug 14, 23 HC Wainwright & Co.
Neutral
May 15, 23 HC Wainwright & Co.
Neutral

Institutional Ownership

Similar stocks

MBRX logo
Moleculin Biotech (MBRX)
PSTV logo
Plus Therapeutics (PSTV)
TRIB logo
Trinity Biotech (TRIB)
ICU logo
SeaStar Medical Holding (ICU)
STRM logo
Streamline Health Solutions (STRM)
PETV logo
PetVivo Holdings (PETV)
ABVC logo
ABVC BioPharma (ABVC)
RLYB logo
Rallybio (RLYB)
IBIO logo
iBio (IBIO)
  • What is the ticker symbol for Co-Diagnostics?
  • Does Co-Diagnostics pay dividends?
  • What sector is Co-Diagnostics in?
  • What industry is Co-Diagnostics in?
  • What country is Co-Diagnostics based in?
  • When did Co-Diagnostics go public?
  • Is Co-Diagnostics in the S&P 500?
  • Is Co-Diagnostics in the NASDAQ 100?
  • Is Co-Diagnostics in the Dow Jones?
  • When was Co-Diagnostics's last earnings report?
  • When does Co-Diagnostics report earnings?
  • Should I buy Co-Diagnostics stock now?

What is the ticker symbol for Co-Diagnostics?

The ticker symbol for Co-Diagnostics is NASDAQ:CODX

Does Co-Diagnostics pay dividends?

No, Co-Diagnostics does not pay dividends

What sector is Co-Diagnostics in?

Co-Diagnostics is in the Healthcare sector

What industry is Co-Diagnostics in?

Co-Diagnostics is in the Medical Devices industry

What country is Co-Diagnostics based in?

Co-Diagnostics is headquartered in United States

When did Co-Diagnostics go public?

Co-Diagnostics's initial public offering (IPO) was on July 12, 2017

Is Co-Diagnostics in the S&P 500?

No, Co-Diagnostics is not included in the S&P 500 index

Is Co-Diagnostics in the NASDAQ 100?

No, Co-Diagnostics is not included in the NASDAQ 100 index

Is Co-Diagnostics in the Dow Jones?

No, Co-Diagnostics is not included in the Dow Jones index

When was Co-Diagnostics's last earnings report?

Co-Diagnostics's most recent earnings report was on Mar 27, 2025

When does Co-Diagnostics report earnings?

The next expected earnings date for Co-Diagnostics is May 9, 2025

Should I buy Co-Diagnostics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page